Niclosamide - 98%, high purity , CAS No.50-65-7

Item Number

N130841

• Synonyms: NCGC00015735-07 | SCHEMBL67182 | Spectrum5_001083 | 2',5-Dichloro-4'-nitrosalicylanilide | CHEBI:7553 | BAY-2353 | Niclocide (TN) | Vermitid | CCRIS 3437 | Bayluscid | DTXCID5020362 | NICLOSAMIDE [USAN] | Spectrum3_000667 | Tredemine | Bayer 2353 | N-(2'-
• Specifications & Purity: Moligand™, ≥98%
• Biochemical and Physiological Mechanisms: Antihelminthic, anticancer and protonophric agent. STAT3 inhibitor (IC 50 = 0.25 μM). Shown to inhibit a number of downstream signaling pathways including mTORC1, Wnt/β-catinin, NF-κB, notch and ROS.
• Storage Temp: Argon charged
• Shipped In: Normal
• Grade: Moligand™
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

Niclosamide is an inhibitor of the Stat3 signaling pathway. Niclosamide inhibits the activation, nuclear translocation and transactivation of Stat3. Niclosamide displays selectivity for Stat3 over Stat1, Stat5, JAK1, JAK2 and Src kinases. Niclosamide inhibits the transcription of Stat3 target genes and induces cell growth inhibition, apoptosis and cell cycle arrest of cancer cells with constitutively active Stat3. Niclosamide is also a FRAP inhibitor via reversible inhibition of mTORC1 signaling and stimulates autophagy in vitro. Niclosamide displays antineoplastic effects in acute myelogenous leukemia (AML) stem cells.
An inhibitor of the Stat3 signaling pathway and also a FRAP inhibitor.